Related Experiment Video
Updated: Nov 10, 2025
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.0K
Are COPD Prescription Patterns Aligned with Guidelines? Evidence from a Canadian Population-Based Study
Taraneh Bahremand1, Mahyar Etminan2, Nardin Roshan-Moniri1
1Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
Summary
Chronic Obstructive Pulmonary Disease (COPD) patients show low use of single inhaled therapies and high use of combinations, with general practitioners more likely than specialists to tailor treatments based on exacerbation history.
Area of Science:
- Pulmonary Medicine
- Health Services Research
- Pharmacotherapy
Background:
- Current Chronic Obstructive Pulmonary Disease (COPD) guidelines emphasize exacerbation history for selecting long-term inhaled therapies.
- Understanding population-level prescription trends is crucial for optimizing COPD management.
Purpose of the Study:
- To analyze trends in filled inhaled prescriptions over the course of COPD.
- To investigate the relationship between exacerbation history and inhaled therapy choices.
Main Methods:
- Retrospective cohort study using administrative health data from British Columbia, Canada (1997-2015).
- Quantified annual filled prescriptions for long-acting inhaled medications.
- Used generalized linear models to assess the association between frequent exacerbator status and prescription filling.
Main Results:
- 132,004 COPD patients were analyzed; inhaled corticosteroids (ICS) were most common (49.9%), followed by long-acting beta-2 agonists (LABA, 31.8%), and long-acting muscarinic antagonists (LAMA, 10.4%) in the first year.
- Combination therapies, particularly ICS+LABA (30.7%), were used by 39.0% of patients initially.
- Triple therapy showed the strongest association with exacerbation history (OR 2.68 for GPs, 2.02 for specialists), with stronger links observed for general practitioners.
Conclusions:
- Low utilization of LAMA monotherapy and high use of ICS-containing combination therapies were observed.
- Specialists were less likely than general practitioners to align inhaled therapy choices with patient exacerbation history.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
525
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
525
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.7K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.7K
01:20COPD: Pathogenesis and Clinical Features
1.5K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K